Accuray (ARAY) Cash from Investing Activities Growth (5y) (2015 - 2026)
Accuray (ARAY) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Accuray | 37.58 Mn | -2.12 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -52.57% |
| Sep 30, 2025 | -46.38% |
| Mar 31, 2025 | -66.43% |
| Dec 31, 2024 | -4.40% |
| Sep 30, 2024 | 2.44% |
| Mar 31, 2024 | -25.23% |
| Dec 31, 2023 | -15.19% |
| Sep 30, 2023 | 7.38% |
| Mar 31, 2023 | -17.31% |
| Dec 31, 2022 | -9.20% |
| Sep 30, 2022 | -6.49% |
| Mar 31, 2022 | -17.39% |
| Dec 31, 2021 | -94.30% |
| Sep 30, 2021 | -17.98% |
| Mar 31, 2021 | 21.81% |
| Dec 31, 2020 | 24.54% |
| Sep 30, 2020 | 35.21% |
| Jun 30, 2020 | 44.40% |
| Mar 31, 2020 | 31.26% |